Visceral Leishmaniasis Treatment Outcome and Associated Factors in Northern Ethiopia

Table 2

Medication related characteristics of VL patients at ACSH, Tigray Region, Northern Ethiopia, June 2016–April 2018.

Characteristics	Category	Frequency (%)
VL Treatment	SSG + PM	106 (71.6)
	LAMB	42 (28.4)
Concomitant treatment	Blood transfusion	36 (24.3)
	Antibiotics	15 (10.3)
	Anti-TB	36 (24.3)
	ART	25 (16.9)
Treatment outcome	Cured	130(87.9)
	Treatment failure	10 (6.7)
	Death	08 (5.4)

ART: antiretroviral therapy, LAMB: liposomal amphotericin B, PM: paromomycin, and SSG: sodium stibogluconate.